Members
Events
Two days in Lund on engineering immune cells directly inside the body, spanning synthetic immunology, gene delivery and translation, co-organised by three Swedish universities.
Medicon Valley Alliance devotes one of five sessions at its 2026 summit to building a leading cell and gene therapy hub in the region, alongside the EU Biotech Act, life science funding and cyber resilience.
A one-day meeting in Ljubljana on where cell, tissue and gene therapy stands, from early science to manufacturing, translation and regulation. Free to attend, with registration open until the end of October.
The third edition of Flemingsberg's translational research conference, with sessions on experimental, translational and clinical work in the area and an abstract programme with awards for the nine strongest submissions.
News
Bioprocess development at Testa Center in Uppsala is now part-funded again: up to five weeks of access per project, with 70 percent of the access fee covered for academic projects and 50 percent for companies. Weeks are allocated first come, first served and must be used by 30 April 2027.
A pre-GMP laboratory in Western Sweden will let ATMP developers prove out their manufacturing processes before committing to a GMP facility. It is one of two resources in Precisionsplattformen, backed by SEK 25 million in EU regional development and Västra Götalandsregionen funding.
The Royal Swedish Academy of Engineering Sciences has set out what Sweden needs to change to hold its position in advanced therapies. The IVA ATMP report asks for three national super-ecosystems, a transferable fast-track voucher at EU level and clearer national guidance on the hospital exemption.
The European Society of Gene and Cell Therapy is looking for its next ECR Board Member. Are you a PhD student or post-doc in gene and cell therapy? Applications close 15 May 2026.
Doctoral Course: From Research to ATMP Treatment
EIB backs Swedish biotech scale-up BioLamina with €20 million to enable stem cell technologies targeting diseases such as type 1 diabetes, Parkinson’s disease, and heart failure
Learn more about the Health Technology Assessment related issues of your ATMP development.
Support in navigating ATMP development needs prompting the right competence, need, and time.
Find or advertise ATMP relevant job opportunities.
The ATMP Sweden newsletter provides updates on Swedish ATMP- and association developments.